Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Startups & Unicorns companies in Levodopa
by Most News Heat in the world in 2018

The Levodopa top 10 is Discovery PatSnap’ annual ranking of the top 10 Most News Heat Levodopa Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Lazar Partners Ltd.
Health care,Robotics,Journalism,
...[+2]
news: 16
2
Genève, Switzerland
Health care,Apomorphine,Safinamide,
...[+1]
news: 11
3
M B A Consulting Beijing Co Ltd.
Beijing, China
news: 3
4
news: 3
5
Coeptis Therapeutics, Inc.
news: 3
6
Medicine,Medical equipment,Health care,
...[+2]
news: 2
7
Elise Technologies SA
Île-de-France, France
Social media,Advertising,Big data,
...[+2]
news: 2
8
Wien, Austria
news: 2
9
Melior Ai, Inc.
news: 2
10
BLOCK M.D.
Bangkok Metropolis, Thailand
Health information exchange,Big data,Health care,
...[+2]
news: 2
Page generation time: May 14 2025